COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Announces the Appointment of Michael Listgarten as General Counsel

May 03, 2023



« back to news page